Recent
price
P/E
ratio
div
yld
- -
ROIC.AI
Arbutus Biopharma (ABUS) Reports Q1 Loss, Misses Revenue Estimates
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
Arbutus Biopharma Corp Reports Q1 2024 Earnings: A Detailed Financial Review
Arbutus Biopharma GAAP EPS of -$0.10 beats by $0.01, revenue of $1.53M misses by $1.19M
Arbutus Announces Retirement of Chief Scientific Officer, Michael J. Sofia, PhD, Effective December 31, 2024
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Are Medical Stocks Lagging Arbutus Biopharma (ABUS) This Year?
Arbutus Biopharma Announces Q1 2024 Financial Update
Arbutus Biopharma Announces Q1 2024 Financial Update
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Arbutus to Report First Quarter 2024 Financial Results and Provide Corporate Update
Arbutus Biopharma Wins Favorable Ruling Against Moderna
Arbutus Biopharma Wins Favorable Ruling Against Moderna
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Arbutus Biopharma Announces Claim Construction Ruling in its Ongoing Patent Infringement Lawsuit Against Moderna
Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)
Analysts Are Bullish on These Healthcare Stocks: Atossa Therapeutics (ATOS), Arbutus Biopharma (ABUS)
Moderna shares fall after judge sides with Arbutus in patent fight
•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.•
in mil. unless spec.